Zoetis Introduces TRIAMULOX™
August 10, 2016 —
Today, Zoetis added TRIAMULOX™ (tiamulin hydrogen fumarate) to its enteric and respiratory disease management portfolio. TRIAMULOX is a proven water-soluble treatment that can be administered to pigs of any age through drinking water to help pork producers and veterinarians combat swine dysentery caused by Brachyspira hyodysenteriae (SD) and swine pneumonia caused by Actinobacillus pleuropneumoniae (APP). [Source: https://www.zoetisus.com/news-and-media/zoetis-introduces-triamulox.aspx Zoetis Press Release, Aug. 4, 2016]
“Swine dysentery has made a resurgence during the past decade and is a costly disease for pork producers. Producers can experience as high as 30% to 90% mortality1 and significant drops in average daily gain and feed conversion2 from an SD outbreak, so they need a reliable, whole-herd treatment,” said Abigail Redalen, DVM, Pork Technical Services, Zoetis. “We encourage producers to work with their veterinarians on diagnosing SD and deciding if whole-herd treatment is right for their pigs.”
Withdraw medicated water 3 days before slaughter after use at 3.5 mg per pound and 7 days before slaughter after use at 10.5 mg per pound. Refer to label for complete directions for use, precautions, and warnings.
To learn more about TRIAMULOX, contact your Zoetis representative or visit zoetisUS.com.
- Next story: Mycoplasma Hyopneumoniae does not Affect the Interferon-Related Anti-Viral Response but Predisposes the Pig to a Higher Inflammation Following Swine Influenza Virus Infection
- Next in category: Dr. Clavijo joins VPDAM Department at Iowa State University
- Previous in category: Merial to Merge with Boehringer Ingelheim
- Previous story: Comparison of Brachyspira hyodysenteriae Isolates Recovered from Pigs in Apparently Healthy Multiplier Herds with Isolates from Herds with Swine Dysentery